Renal Insufficiency and the Impact of Contrast Agents
2022; Pulsus Group; Linguagem: Inglês
10.1002/9781119697367.ch28
ISSN1755-5310
AutoresCarlo Briguori, Michael Donahue, Carmen D’Amore,
Tópico(s)Traumatic Brain Injury and Neurovascular Disturbances
ResumoChapter 28 Renal Insufficiency and the Impact of Contrast Agents Carlo Briguori, Carlo BriguoriSearch for more papers by this authorMichael Donahue, Michael DonahueSearch for more papers by this authorCarmen D'Amore, Carmen D'AmoreSearch for more papers by this author Carlo Briguori, Carlo BriguoriSearch for more papers by this authorMichael Donahue, Michael DonahueSearch for more papers by this authorCarmen D'Amore, Carmen D'AmoreSearch for more papers by this author Book Editor(s):George D. Dangas MD, MACC, MSCAI, FAHA, FESC, George D. Dangas MD, MACC, MSCAI, FAHA, FESC Professor of Medicine (Cardiology) & Surgery (Vascular) Professor of Cardiology Adjunct Professor of Internal Medicine Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, New York, NY, USA National Kapodistrian University of Athens, Greece Medical University of Vienna, AustriaSearch for more papers by this authorCarlo Di Mario MD, PhD, FRCP, FACC, FSCAI, FESC, Carlo Di Mario MD, PhD, FRCP, FACC, FSCAI, FESC Professor of Cardiology Director of the Structural Interventional Cardiology Division Honorary Consultant University of Florence University Hospital Careggi, Florence, Italy Cardiologist Royal Brompton Hospital, London, UKSearch for more papers by this authorHolger Thiele MD, Holger Thiele MD Professor of Cardiology at University of Leipzig Heart Center Leipzig at University of Leipzig, Leipzig, GermanySearch for more papers by this authorPeter Barlis MBBS, MPH, PHD, FACC, FESC, FRACP, Peter Barlis MBBS, MPH, PHD, FACC, FESC, FRACP Professor of Cardiology Interventional Cardiologist University of Melbourne, Melbourne, Victoria, Australia St Vincent's & Northern Hospitals Victoria, AustraliaSearch for more papers by this authorTayo Addo MD, Tayo Addo MD Dallas, TX, USASearch for more papers by this authorBimmer Claessen MD, Bimmer Claessen MD Amsterdam, NetherlandsSearch for more papers by this authorChristian Hengstenberg MD, Christian Hengstenberg MD Vienna, AustriaSearch for more papers by this authorNicholas Kipshidze MD, Nicholas Kipshidze MD New York, NY, USASearch for more papers by this author First published: 06 May 2022 https://doi.org/10.1002/9781119697367.ch28 AboutPDFPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Summary Chronic kidney disease (CKD) is a global health burden with a high economic cost to health systems and represents an independent risk factor for cardiovascular disease. Myocardial revascularization in patients with CKD by either percutaneous or surgical approaches is gravated by a higher rate of complications than in patients without CKD. Contrast-associated acute kidney injury represents one of the most common complications in this subset of patients. It was hypothesized that to alkalize the tubular urine with sodium bicarbonate may limit the renal damage induced by the contrast agents by reducing the amount of free radicals pH-dependent. Hemofiltration is expensive, time consuming, logistically cumbersome and associated with significant risks. Its effectiveness compared to other less expensive strategies is not well established so that this treatment modality should be reserved for patients who already have fairly advanced renal insufficiency. References Jha V , Garcia-Garcia G , Iseki K , et al . Chronic kidney disease: global dimension and perspectives . The Lancet 2013 ; 382 ( 9888 ): 260 – 72. Gansevoort RT , Correa-Rotter R , Hemmelgarn BR , et al . Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention . The Lancet 2013 ; 382 ( 9889 ): 339 – 52 . Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group . KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease . Kidney Int Suppl 2013 ; 3 : 1 – 150. de Lusignan S , Tomson C , Harris K , et al . UK Prevalence of Chronic Kidney Disease for the Adult Population Is 6.76% Based on Two Creatinine Readings [Erratum] . Nephron Clinical Practice. 2012 ; 120 : c107 Levey AS , Beto JA , Coronado BE , et al . Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease . Am J Kidney Dis 1998 ; 32 : 853 – 906 . Matsushita K , van der Velde M , Astor BC et al . Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative metaanalysis . The Lancet 2010 ; 375 : 2073 – 2081 . Hillis GS , Croal BL , Buchan KG , et al . Renal function and outcome from coronary artery bypass grafting: impact on mortality after a 2.3-year follow-up . Circulation 2006 ; 113 : 1056 – 1062 . Cooper WA , O'Brien SM , Thourani VH , et al . Impact of renal dysfunction on outcomes of coronary artery bypass surgery: Results from the Society of Thoracic Surgeons National Adult Cardiac Database . Circulation 2006 ; 113 : 1063 – 1070 . Hassani SE , Chu WW , Wolfram RM et al . Clinical outcomes after percutaneous coronary intervention with drug-eluting stents in dialysis patients . J Invasive Cardiol. 2006 ; 18 ( 6 ), 273 – 277 . Hemmelgarn BR , Southern D , Culleton BF , et al . Survival after coronary revascularization among patients with kidney disease . Circulation 2004 ; 110 : 1890 – 1895 . Aoki J , Ong AT , Hoye A , et al . Five year clinical effect of coronary stenting and coronary artery bypass grafting in renal insufficient patients with multivessel coronary artery disease: Insights from ARTS trial . Eur Heart J. 2005 ; 26 : 1488 – 1493 . Briguori C , Airoldi F , Chieffo A , et al . Renal function and drug-eluting stent . Int J Cardiol 2010 ; 142 ( 1 ): 92 – 4 . Iakovou I , Schmidt T , Bonizzoni E , et al . Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents . JAMA 2005 ; 293 ( 17 ): 2126 – 30. Bellomo R , Ronco C , Kellum JA , et al . Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group . Crit Care. 2004 Aug; 8 ( 4 ): R204 – 12 Mehta RL , Kellum JA , Shah SV , et al . Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury . Crit Care 2007 ; 11 : R31 Nash K , Hafeez A , Hou S . Hospital-acquired renal insufficiency . Am J Kidney Dis 2002 ; 39 : 930e6 Rewa O , Bagshaw SM . Acute kidney injury-epidemiology, outcomes and economics . Nat Rev Nephrol. 2014 ; 10 : 193 – 207 . McCullough PA . Contrast-Induced Acute Kidney Injury . J Am Coll Cardiol. 2008 ; 51 : 1419 – 1428 . Wong PC , Li Z , Guo J , Zhang A . Pathophysiology of contrast-induced nephropathy . Int J Cardiol. 2012 ; 158 : 186e92 . Tumlin J , Stacul F , Adam A , et al . Pathophysiology of contrast-induced nephropathy . Am J Cardiol. 2006 ; 98 : 14K – 20K Romano G , Briguori C , Quintavalle C et al . Contrast agents and renal cell apoptosis . Eur Health J. 2008 ; 29 : 2569 – 2576 . Hardiek K , Katholi RE , Ramkumar V , Deitrick C . Proximal tubule cell response to radiographic contrast media . Am J Physiol Renal Physiol. 2001 ; 280 F61 – F70 . Heyman SN , Rosen S , Rosenberger C . Renal parenchymal hypoxia, hypoxia adaptation, and the pathogenesis of radiocontrast nephropathy . Clin J Amer Soc Neph. 2008 ; 3 : 288 – 96 . Thongprayoon C , Cheungpasitporn W , Srivali N , et al . Acute kidney injury after transcatheter aortic valve replacement: a systematic review and meta-analysis . Am J Nephrol 2015 ; 41 : 372 – 82 . McCullough PA , Choi JP , Feghali GA , et al . Contrast-Induced Acute Kidney Injury . J Am Coll Cardiol. 2016 Sep 27; 68 ( 13 ): 1465 – 1473 . Guitterez NV , Diaz A , Timmis GC , et al . Determinants of serum creatinine trajectory in acute contrast nephropathy . J Interv Cardiol. 2002 ; 15 : 349 – 354. Tenstad O , Roald AB , Grubb A , Aukland K. Renal handling of radio labelled human cystatin C in the rat . Scand J Clin Lab Invest. 1996 ; 56 ( 5 ): 409 – 414 . Sjostrom P , Tidman M , Jones I. The shorter T1/2 of cystatin C explains the earlier change of its serum level compared to serum creatinine . Clin Nephrol. 2004 ; 62 : 241 – 2 Briguori C , Visconti G , Rivera NV , et al . Cystatin C and contrastinduced acute kidney injury . Circulation. 2010 ; 121 ( 19 ): 2117 – 2122 . Solomon RJ , Mehran R , Natarajan MK , et al . Contrast-induced nephropathy and long-term adverse events: cause and effect? Clin J Am Soc Nephrol. 2009 ; 4 ( 7 ): 1162 – 1169 . Ferguson MA , Vaidya VS , Bonventre JV . Biomarkers of nephrotoxic acute kidney injury . Toxicology 2008 ; 245 : 182 – 93 . Levin A , Pate GE , Shalansky S , et al . N-acetylcysteine reduces urinary albumin excretion following contrast administration: evidence of biological effect . Nephrol Dial Transplant Bernier GM . beta 2-Microglobulin: structure, function and significance . Vox Sang 1980 ; 38 : 323 – 7 . Mishra J , Ma Q , Kelly C , et al . Kidney NGAL is a novel early marker of acute injury following transplantation . Pediatr Nephrol. 2006 ; 21 ( 6 ): 856 – 863 . 28. McCullough PA , Williams FJ , Stivers DN , et al . Neutrophil gelatinase-associated lipocalin: a novel marker of contrast nephropathy risk . Am J Nephrol. 2012 ; 35 ( 6 ): 509 – 14 . Tasanarong A , Hutayanon P , Piyayotai P . Urinary Neutrophil Gelatinase-Associated Lipocalin predicts the severity of contrast-induced acute kidney injury in chronic kidney . BMC Nephrology 2013 ; 14 : 270 . Haase M , Devarajan P , Haase-Fielitz A , et al . The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies . J Am Coll Cardiol. 2011 ; 57 ( 17 ): 1752 – 61 . Moore NN1 , Lapsley M , Norden AG , Does N-acetylcysteine prevent contrast-induced nephropathy during endovascular AAA repair? A randomized controlled pilot study . J Endovasc Ther. 2006 ; 13 : 660 – 6. Bonventre JV . Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more . Nephrol Dial Transplant 2009 ; 24 : 3265 – 8 . He H , Li W , Qian W , et al . Urinary interleukin-18 as an early indicator to predict contrast-induced nephropathy in patients undergoing percutaneous coronary intervention . Exp Ther Med 2014 ; 8 : 1263 – 6 . Ling W , Zhaohui N , Ben H , et al . Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography . Nephron Clin Pract 2008 ; 108 : c176 – c181 . Bulent Gul CB , Gullulu M , Oral B , et al . Urinary IL-18: a marker of contrast-induced nephropathy following percutaneous coronary intervention? Clin Biochem 2008 ; 41 : 544 – 7 . Lichosik M , Jung A , Jobs K . Interleukin 18 and neutrophil-gelatinase associated lipocalin in assessment of the risk of contrast-induced nephropathy in children . Cent Eur J Immunol 2015 ; 40 : 447 – 53 . Schunk SJ , Zarbock A , Meersch M et al . Association between urinary dickkopf-3, acute kidney injury, and subsequent loss of kidney function in patients undergoing cardiac surgery: an observational cohort study The Lancet 2019 ; 394 : 488 – 96 . Murakami R , Tajima H , Kumazaki T , Yamamoto K. Effect of iodixanol on renal function immediately after abdominal angiography. Clinical comparison with iomeprol and ioxaglate . Acta Radiol. Jul 1998 ; 39 ( 4 ): 368 – 371 . Seeliger E , Flemming B , Wronski T , et al . Viscosity of contrast media perturbs renal hemodynamics . J Am Soc Nephrol. Nov 2007 ; 18 ( 11 ): 2912 – 2920. Aspelin P , Aubry P , Fransson SG , et al . Nephrotoxic effects in high-risk patients undergoing angiography . NEJM . Feb 6 2003 ; 348 ( 6 ): 491 – 499. Wessely R. The Contrast Media and Nephrotoxicity Following Coronary Revascularization by Angioplasty" (CONTRAST) study. Late-Breaking Clinical Trials session at the SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit (SCAI-ACCi2) in Chicago , April 1 2008. Rudnick M , Davidson C , Laskey W , et al . Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficieny (VALOR) trial . Am Heart J 2008. Sahani DV , Soulez G , Chen KM , et al . A comparison of the efficacy and safety of iopamidol-370 and iodixanol-320 in patients undergoing multidetector-row computed tomography . Investigative Radiology. Dec 2007 ; 42 ( 12 ): 856 – 861 . Solomon RJ , Natarajan MK , Doucet S , et al . Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease . Circulation. Jun 26 2007 ; 115 ( 25 ): 3189 – 3196. Kushner FG , Hand M , Smith Jr SC , et al . 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines . J Am Coll Cardiol 2009 ; 54 : 2205e41 . Mehran R , Aymong ED , Nikolsky E , et al . A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation . J Am Coll Cardiol 44 : 1393 – 1399 , 2004 . Gurm HS , Seth M , Kooiman J , Share DA . Novel Tool for Reliable and Accurate Prediction of Renal Complications in Patients Undergoing Percutaneous Coronary Intervention . J Am Coll Cardiol. 2013 Jun 4; 61 ( 22 ): 2242 – 8. Tsai T , Patel U , Chang T , et al . A validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI Registry . Circ Cardiovasc Qual Outcomes 2012 ; 5 : A6 . Tsai TT , Patel UD , Chang TI , et al . Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI Registry . J Am Coll Cardiol Intv 2014 ; 7 : 1 – 9 . Marenzi G , Assanelli E , Campodonico J , et al . Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality . Ann Intern Med. 2009 ; 150 : 170 – 7 . Freeman RV , O'Donnell M , Share D , et al . Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose . Am J Cardiol. 2002 ; 90 ( 10 ): 1068 – 1073. Laskey WK , Jenkins C , Selzer F , et al . Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention . J Am Coll Cardiol. 2007 ; 50 ( 7 ): 584 – 590 . Neumann FJ , Sousa-Uva M , Ahlsson A , et al . 2018 ESC/EACTS Guidelines on myocardial revascularization . Eur Heart J. 2019 Jan 7; 40 ( 2 ): 87 – 165 . Nayak KR1 , Mehta HS , Price MJ , et al . A novel technique for ultra-low contrast administration during angiography or intervention . Catheter Cardiovasc Interv . 2010 Jun 1 ; 75 ( 7 ): 1076 – 83 . doi: 10.1002/ccd.22414 . Ali ZA , Karimi Galougahi K , Nazif T , et al . Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study . Eur Heart J. 2016 Oct 21; 37 ( 40 ): 3090 – 3095 . Epub 2016 Mar 7. Desch S , Fuernau G , Pöss , J , et al . Impact of a novel contrast reduction system on contrast savings in coronary angiography – The DyeVert randomised controlled trial . Int J Cardiol. 2018 ; 257 , 50 – 53 . Gurm HS , Mavromatis K , Bertolet B , et al . Minimizing radiographic contrast administration during coronary angiography using a novel contrast reduction system: A multicenter observational study of the DyeVert™ plus contrast reduction system . Catheter Cardiovasc Interv. 2019 Jun 1; 93 ( 7 ): 1228 – 1235. Javanbakht M , Hemami MR , Mashayekhi A , et al . DyeVert™ PLUS EZ System for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Diagnostic Coronary Angiography and/or Percutaneous Coronary Intervention: A UK-Based Cost-Utility Analysis . Pharmacoecon Open . 2020 Jan 27. doi: 10.1007/s41669-020-00195-x . [Epub ahead of print]. E. C. Nijssen , R. J. Rennenberg , P. J. Nelemans et al ., " Pro- phylactic hydration to protect renal function from intravas- cular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial ," The Lancet , vol. 389 , no. 10076 , pp. 1312 – 1322 , 2017. Stevens MA , McCullough PA , Tobin KJ , et al . A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: Results of the P.R.I.N.C.E. study . J Am Coll Cardiol. 1999 ; 33 : 403 – 11 . Dorval J-F , Dixon SR , Zelman RB , et al . Feasibility study of the RenalGuard balanced hydration system: A novel strategy for the prevention of contrast-induced nephropathy in high risk patients . Int J Cardiol. 2013 ; 166 : 482 – 6 . Briguori C , Visconti G , Focaccio F , et al . Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in High-Risk Patients for Contrast-Induced Acute Kidney Injury . Circulation. 2011 ; 124 : 1260 – 1269. Marenzi G , Ferrari C , Marana I , et al . Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial . JACC Cardiovasc Interv. 2012 ; 5 : 90 – 7 . S.S. Brar , V. Aharonian , P. Mansukhani et al ., " Haemody- namic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial ," The Lancet , vol. 383 , no. 9931 , pp. 1814 – 1823 , 2014 . Briguori C , D'Amore C , De Micco et al . Left Ventricular End Diastolic Pressure Versus Urine Flow Ratio–Guided Hydration in High-Risk Patients for Q1 Contrast-Associated Acute Kidney Injury . JACC: Cardiovascular Interventions 2020 In press. M. Maioli , A. Toso , M. Leoncini et al ., " Bioimpedance-guidedhydration for the prevention of contrast-inducedkidneyinjury: the HYDRA study ," J Am Coll Cardiol , vol. 71 , no. 25 , pp. 2880 – 2889 , 2018 . Merten GJ , Burgess WP , Gray LV , et al . Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial . JAMA 2004 ; 291 : 2328 – 2334 . Briguori C , Airoldi F , D'Andrea D , et al . Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies . Circulation. 2007 ; 115 ( 10 ): 1211 – 217 Trivedi H , Nadella R , Szabo A. Hydration with sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of randomized controlled trials . Clin Nephrol 2010 ; 74 : 288 – 96 . Kunadian V , Zaman A , Spyridopoulos I , Qiu W . Sodium bicarbonate for the prevention of contrast induced nephropathy: a meta-analysis of published clinical trials . Eur J Radiol 2011 ; 79 : 48 – 55 . Tamai N , Ito S , Nakasuka K , et al . Sodium bicarbonate for the prevention of contrast-induced nephropathy:the efficacy of high concentration solution . J Invasive Cardiol 2012 ; 24 : 439 – 42 . Randomized Trial of Bicarbonate or Saline Study for the Prevention of Contrast-Induced Nephropathy in Patients with CKD . Clin J Am Soc Nephrol. 2015 Sep 4; 10 ( 9 ): 1519 – 24 . Solomon R , Gordon P , Manoukian SV , et al . BOSS Trial Investigators . Randomized Trial of Bicarbonate or Saline Study for the Prevention of Contrast-Induced Nephropathy in Patients With CKD . Clin J Am Soc Nephrol. 2015 Sep 4; 10 ( 9 ): 1519 – 24 . Weisbord SD , Gallagher M , Jneid H , et al . PRESERVE Trial Group. Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine . N Engl J Med. 378 ( 2018 ) 603 – 614 . Briguori C , Airoldi F , D'Andrea D , et al . Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies . Circulation. 2007 ; 115 ( 10 ): 1211 – 1217 . ACT Investigators . Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT) . Circulation. 2011 ; 124 : 1250 – 9. Quintavalle C , Fiore D , De Micco F , et al . Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury . Circulation. 2012 ; 126 : 3008 – 16. Spargias K , Alexopoulos E , Kyrzopoulos S , et al . Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention . Circulation. 2004 Nov 2; 110 ( 18 ): 2837 – 42. Li H , Wang C , Liu C , et al . Efficacy of short-term statin treatment for the prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography/percutaneous coronary intervention: a meta-analysis of 21 randomized controlled trials . Am J Cardiovasc Drugs. 2016 ; 16 : 201 – 219 . Zhou X , Dai J , Xu X , et al . Comparative efficacy of statins for prevention of con- trast-induced acute kidney injury in patients with chronic kidney disease: a network meta-analysis . Angiology. 2019 ; 70 : 305 – 316 . Han Y , Zhu G , Han L , et al . Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with dia- betes and chronic kidney disease . J Am Coll Cardiol 2014 ; 63 : 62 – 70 . Bainey KR , Rahim S , Etherington K , et al . Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: results from the angioten- sin converting enzyme inhibitor/angiotensin receptor blocker and contrast induced nephropathy in patients receiving cardiac catheterization (CAPTAIN) trial . Am Heart J. 2015 ; 170 : 110 – 116 . Vogt B , Ferrari P , Schonholzer C , et al . Prophylactichemodialysisafterradiocontrast media in patients with renalinsufficiencyispotentiallyharmful . Am J Med. 2001 ; 111 ( 9 ): 692 – 698 . Lee PT , Chou KJ , Liu CP , et al . Renalprotection for coronaryangiography in advancedrenalfailurepatients by prophylactichemodialysis. A randomizedcontrolled trial . J Am Coll Cardiol. 2007 ; 50 ( 11 ): 1015 – 1020. Marenzi G , Marana I , Lauri G , et al . The prevention of radiocontrast agent-induced nephropathy by hemofiltration . N Engl J Med. 2003 ; 349 ( 14 ): 1333 – 1340 Przyklenk K , Bauer B , Ovize M , et al . Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion . Circulation. 1993 ; 87 ( 3 ): 893 . Hausenloy DJ , Yellon DM . Remote ischaemic preconditioning: underlying mechanisms and clinical application . Cardiovasc Res. 2008 ; 79 ( 3 ): 377. Igarashi G , Iino K , Watanabe H , Ito H . Remote ischemic pre-conditioning alleviates contrast-induced acute kidney injury in patients with moderate chronic kidney disease . Circ J. 2013 ; 77 ( 12 ): 3037 – 44 . Er F , Nia AM , Dopp H , et al . Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot Ren Pro Trial (Renal Protection Trial) . Circulation 2012 ; 126 : 296 – 303 . Deftereos S , Giannopoulos G , Tzalamouras V , et al . Renoprotective effect of remote ischemic postconditioning by intermittent balloon inflations in patients undergoing percutaneous coronary intervention . J Am Coll Cardiol. 2013 May 14; 61 ( 19 ): 1949 – 55 . Bonventre JV . Limb ischemia protects against contrast-induced nephropathy . Circulation 2012 ; 126 ( 4 ): 384 – 7 . Moretti C , Cerrato E , Cavallero E , et al . The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS Cardio Group I): A randomized controlled trial . Int J Cardiol. 2018 Apr15; 257 : 1 – 6 . doi: 10.1016/j.ijcard.2017.12.033 . Interventional Cardiology: Principles and Practice, Third Edition ReferencesRelatedInformation
Referência(s)